What Happened?
Cambridge, MA-based Compass-Therapeutics Appointed Thomas Schuetz as Chief Executive Officer
About the Company
Compass Therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. Compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and top-tier academic laboratories around the world. Novel scientific insights are validated and explored deeply inside our labs before Compass pursues the best proprietary combinations of therapeutics into human clinical trials.
About the Person
Thomas Schuetz is Chief Executive Officer at Compass Therapeutics. Previously, Thomas held various senior HR leadership roles in the industry.
Info Source
News
Short Profile